12-21804904-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_020297.4(ABCC9):​c.4512+1094A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0328 in 152,318 control chromosomes in the GnomAD database, including 120 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.033 ( 120 hom., cov: 32)

Consequence

ABCC9
NM_020297.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.326
Variant links:
Genes affected
ABCC9 (HGNC:60): (ATP binding cassette subfamily C member 9) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is thought to form ATP-sensitive potassium channels in cardiac, skeletal, and vascular and non-vascular smooth muscle. Protein structure suggests a role as the drug-binding channel-modulating subunit of the extra-pancreatic ATP-sensitive potassium channels. Mutations in this gene are associated with cardiomyopathy dilated type 1O. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-21804904-T-G is Benign according to our data. Variant chr12-21804904-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 681259.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0328 (4999/152318) while in subpopulation NFE AF = 0.0495 (3369/68018). AF 95% confidence interval is 0.0481. There are 120 homozygotes in GnomAd4. There are 2356 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 120 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC9NM_020297.4 linkc.4512+1094A>C intron_variant Intron 39 of 39 ENST00000261200.9 NP_064693.2 O60706-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC9ENST00000261200.9 linkc.4512+1094A>C intron_variant Intron 39 of 39 5 NM_020297.4 ENSP00000261200.4 O60706-2

Frequencies

GnomAD3 genomes
AF:
0.0328
AC:
4999
AN:
152200
Hom.:
120
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00912
Gnomad AMI
AF:
0.0329
Gnomad AMR
AF:
0.0314
Gnomad ASJ
AF:
0.0501
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.00496
Gnomad FIN
AF:
0.0427
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0496
Gnomad OTH
AF:
0.0354
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0328
AC:
4999
AN:
152318
Hom.:
120
Cov.:
32
AF XY:
0.0316
AC XY:
2356
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00909
AC:
378
AN:
41574
American (AMR)
AF:
0.0314
AC:
480
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0501
AC:
174
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5194
South Asian (SAS)
AF:
0.00538
AC:
26
AN:
4830
European-Finnish (FIN)
AF:
0.0427
AC:
453
AN:
10614
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0495
AC:
3369
AN:
68018
Other (OTH)
AF:
0.0350
AC:
74
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
251
502
754
1005
1256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0433
Hom.:
223
Bravo
AF:
0.0318
Asia WGS
AF:
0.00404
AC:
15
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.8
DANN
Benign
0.45
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17630922; hg19: chr12-21957838; API